Rothschild Investment Corp IL cut its holdings in AmerisourceBergen Corp. (NYSE:ABC) by 6.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 11,495 shares of the company’s stock after selling 850 shares during the quarter. Rothschild Investment Corp IL’s holdings in AmerisourceBergen were worth $946,000 as of its most recent SEC filing.
A number of other large investors have also added to or reduced their stakes in ABC. Vanguard Group Inc. lifted its stake in AmerisourceBergen by 16.8% in the second quarter. Vanguard Group Inc. now owns 18,910,594 shares of the company’s stock worth $1,612,318,000 after acquiring an additional 2,719,868 shares during the period. Marshall Wace North America L.P. lifted its stake in AmerisourceBergen by 318.9% in the first quarter. Marshall Wace North America L.P. now owns 907,474 shares of the company’s stock worth $72,163,000 after acquiring an additional 690,823 shares during the period. Amundi Pioneer Asset Management Inc. lifted its stake in AmerisourceBergen by 493.2% in the second quarter. Amundi Pioneer Asset Management Inc. now owns 757,887 shares of the company’s stock worth $64,617,000 after acquiring an additional 630,123 shares during the period. Skandinaviska Enskilda Banken AB publ lifted its stake in AmerisourceBergen by 1,584.3% in the second quarter. Skandinaviska Enskilda Banken AB publ now owns 490,101 shares of the company’s stock worth $41,786,000 after acquiring an additional 461,002 shares during the period. Finally, Nuveen Asset Management LLC lifted its position in shares of AmerisourceBergen by 111.5% during the second quarter. Nuveen Asset Management LLC now owns 738,360 shares of the company’s stock valued at $62,953,000 after buying an additional 389,252 shares during the last quarter. 65.95% of the stock is owned by institutional investors.
In other news, insider John G. Chou sold 13,997 shares of the company’s stock in a transaction dated Monday, August 5th. The shares were sold at an average price of $89.58, for a total transaction of $1,253,851.26. Following the transaction, the insider now owns 65,782 shares in the company, valued at $5,892,751.56. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Gina Clark sold 7,800 shares of the company’s stock in a transaction dated Thursday, September 19th. The shares were sold at an average price of $84.96, for a total transaction of $662,688.00. Following the transaction, the executive vice president now owns 23,595 shares in the company, valued at approximately $2,004,631.20. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 109,506 shares of company stock worth $9,412,050. Corporate insiders own 27.80% of the company’s stock.
AmerisourceBergen (NYSE:ABC) last posted its quarterly earnings data on Thursday, August 1st. The company reported $1.76 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.62 by $0.14. AmerisourceBergen had a net margin of 0.54% and a return on equity of 47.88%. The firm had revenue of $45.24 billion for the quarter, compared to the consensus estimate of $45.15 billion. During the same quarter in the prior year, the company posted $1.54 earnings per share. The company’s revenue for the quarter was up 4.9% compared to the same quarter last year. On average, research analysts anticipate that AmerisourceBergen Corp. will post 7.05 EPS for the current fiscal year.
Several research firms have commented on ABC. Morgan Stanley decreased their price target on shares of AmerisourceBergen from $91.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, September 6th. ValuEngine lowered shares of AmerisourceBergen from a “hold” rating to a “sell” rating in a research report on Tuesday, August 6th. TheStreet raised shares of AmerisourceBergen from a “c+” rating to a “b” rating in a research report on Thursday, August 1st. Finally, Deutsche Bank began coverage on shares of AmerisourceBergen in a research report on Thursday, September 12th. They set a “hold” rating and a $91.00 price target for the company. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $87.38.
AmerisourceBergen Company Profile
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Recommended Story: Trading based on a resistance level
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.